IFN-γ-induced MHC class II gene expression is suppressed in endothelial cells by dextran sulfate

Journal of Immunology

Volumn 157, Issue 2, 1996, Pages 864-873

  Lian, Rebecca H ^a   Kotwal, Girish J ^a   Wellhausen, Samuel R ^a   Hunt, Lawrence A ^a   Justus, David E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GLYCOSAMINOGLYCAN; HEPARIN; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; METHIONINE; PROTEOCHONDROITIN SULFATE; PROTEOHEPARAN SULFATE; RECOMBINANT GAMMA INTERFERON; SULFUR 35; TRANSACTIVATOR PROTEIN;

ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING; UMBILICAL VEIN;

BASE SEQUENCE; CELL ADHESION MOLECULES; CYTOKINES; DEXTRAN SULFATE; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HLA-DR ANTIGENS; HUMANS; INTERFERON TYPE II; MOLECULAR SEQUENCE DATA; NUCLEAR PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC; UMBILICAL CORD;

EID: 0030002225     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Baba, M., E. De Clercq, D. Schols, R. Pauwels, R. Snoeck, C. Van Boeckel, G. Van Dedem, N. Kraaijeveld, P. Hobbelen, H. Ottenheijm, and F. Den Hollander. 1990. Novel sulfated polysaccharides: dissociation of anti-human immunodeficiency virus activity from antithrombin activity. J. Infect. Dis. 161:208.
2. Lopalco, L., F. Ciccomascolo, P. Lanza, G. Zoppetti, I. Caramazza, F. Leoni, A. Beretta, and A. G. Siccardi. 1994. Anti-HIV type 1 properties of chemically modified heparins with diminished anticoagulant activity. AIDS Res. Hum. Retroviruses 10:787.
3. McCarthy, R. E., and G. F. Babcock. 1978. Simultaneous stimulation and suppression of two different indicators of the cell-mediated immune response by the immunoregulator dextran sulfate. Immunology 34:927.
4. Kettman, J., A. Soederberg, and I. Lefkovits. 1984. Activation/suppression of the immune response in vitro by antigen and dextran sulfate. 2. The role of T-cell subsets determined by cell separation and partition analysis. Cell. Immunol. 88: 129.
5. Kettman, J. R., A. Soederberg, and I. Lefkovits. 1985. Activation/suppression of the immune response in vitro by antigen and dextran sulfate. I. Analysis by limiting dilution methods. Eur. J. Immunol. 15:708.
6. Bos, N. A., C. G. Meeuwsen, H. deVisser, and R. Benner. 1988. Clonal analysis of the synergistic mitogenic effect of lipopolysaccharide and dextran sulphate on B cell activation, growth, and differentiation into Ig-secreting cells. Immunobiology 176:301.
7. Leong, J. M., P. E. Morrissey, E. Ortega-Barria, M. E. A. Pereira, and J. Coburn. 1995. Hemagglutination and proteoglycan binding by the Lyme disease spirochete, Borrelia burgdorferi. Infect. Immun. 63:874.
8. Callahan, L. N., M. Phelan, M. Mallinson, and M. A. Norcross. 1991. Dextran sulfate blocks antibody binding to the principal neutralizing domain of human immunodeficiency virus type 1 without interfering with gp120-CD4 interactions. J. Virol. 65:1543.
9. Neyts, J., R. Snoeck, D. Schols, J. Balzarini, J. D. Esko, A. Van Schepdael, and E. De Clercq. 1992. Sulfated polymers inhibit the interaction of human cytomegalovirus with cell surface heparan sulfate. Virology 189:48.
10. Mbemba, E., J. C. Gluckman, and L. Gattegno. 1994. Interactions of HIV-1 and HIV-2 envelope glycoproteins with sulphated polysaccharides and mannose-6-phosphate. Glycobiology 4:13.
11. Nakashima, H., O. Yoshida, M. Baba, E. De Clercq, and N. Yamamoto. 1989. Anti-HIV activity of dextran sulphate as determined under different experimental conditions. Antivir. Res. 11:233.
12. Schiebler, W., C. Schmidt, and P. Weber. 1989. Dextran sulfate and pentosan polysulfate (HOE/BAY 946), potent anti-HIV agents inhibit protein kinase C. J. Protein Chem. 8:362.
13. Meylan, P. R., R. S. Kornbluth, I. Zbinden, and D. D. Richman. 1994. Influence of host cell type and V3 loop of the surface glycoprotein on susceptibility of human immunodeficiency virus type 1 to polyanion compounds. Antimicrob. Agents Chemother. 38:2910.
14. De Clercq, E. 1988. Perspectives for the chemotherapy of AIDS. Chemioterapia. 7:357.
15. Abrams, D. I., S. Kuno, R. Wong, K. Jeffords, M. Nash, J. B. Molaghan, R. Gorter, and R. Ueno. 1989. Oral dextran sulfate (UA001) in the treatment of the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann. Intern. Med. 110:183.
16. Tangelder, G. J., and K.-E. Arfors. 1991. Inhibition of leukocyte rolling in venules by protamine and sulfated polysaccharides. Blood 77:1565.
17. Furukawa, K., and V. P. Bhavanandan. 1983. Influences of anionic polysaccharides on DNA synthesis in isolated nuclei and by DNA polymerase α: correlation of observed effects with properties of the polysaccharides. Biochim. Biophys. Ada 740:466.
18. Bevilacqua, M. P., J. S. Pober, D. L. Mendrick, R. S. Cotran, and M. A. Gimbrone, Jr. 1987. Identification of an inducible endothelial-leukocyte adhesion molecule. Proc. Natl. Acad. Sci. USA 84:9238.
19. Bevilacqua, M. P., S. Stengalin, M. A. Gimbrone, and B. Seed. 1989. Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins. Science 243:1160.
20. Albeda, S. M., and C. A. Buck. 1990. Integrins and other cell adhesion molecules. FASEB J. 4:2868.
21. Springer, T. A. 1990. Adhesion receptors of the immune system. Nature 346:425.
22. Dustin, M. L., R. Rothlein, A. K. Bhan, C. A. Dinarello, and T. A. Springer. 1986. Induction by IL 1 and interferon-γ: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245.
23. Myers, C. L., S. J. Wertheimer, J. Schembri-King, T. Parks, and R. W. Wallace. 1992. Induction of ICAM-1 by TNF-α, IL-1β, and LPS in human endothelial cells after down-regulation of PKC. Am. J. Physiol. 263:C767.
24. + entry. J. Biol. Chem. 266:18119.
25. Lee, S. C., M. Collins, P. Vanguri, and M. L. Shin. 1992. Glutamate differentially inhibits the expression of class II MHC antigens on astrocytes and microglia. J. Immunol. 148:3391.
26. Panek, R. B., and E. N. Benveniste. 1995. Class II MHC gene expression in microglia: regulation by the cytokines IFN-γ, TNF-α, and TGF-β. J. Immunol. 154:2846.
27. Collins, T., A. J. Korman, C. T. Wake, J. M. Boss, D. J. Kappes, W. Fiers, K. A. Ault, M. A. Gimbrone, Jr., J. L. Strominger, and J. S. Pober. 1984. Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. Proc. Natl. Acad. Sci. USA 81:4917.
28. Wagner, C. R., R. M. Vetto, and D. R. Burger. 1985. Subcultured human endothelial cells can function independently as fully competent antigen-presenting cells. Hum. Immunol. 13:33.
29. Shoskes, D. A., and K. J. Wood. 1994. Indirect presentation of MHC antigens in transplantation. Immunol. Today. 15:32.
30. Pober, J. S., and R. S. Cotran. 1991. Immunologic interactions of T lymphocytes with vascular endothelium. Adv. Immunol. 50:261.
31. + allogeneic vascular endothelium. Transplantation 56:128.
32. Glimcher, L. H., and C. J. Kara. 1992. Sequences and factors: a guide to MHC class-II transcription. Annu. Rev. Immunol. 10:13.
33. Steimle, V., L. A. Otten, M. Zufferey, and B. Mach. 1993. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or Bare Lymphocyte Syndrome). Cell 75:135.
34. Chang, C.-H., J. Fontes, M. Peterlin, and R. A. Flavell. 1994. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J. Exp. Med. 180:1367.
35. Steimle, V., C.-A. Siegrist, A. Mottet, B. Lisowska-Grospierre, and B. Mach. 1994. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 265:106.
36. Chang, C.-H., and R. A. Flavell. 1995. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J. Exp. Med. 181: 765.
37. Voyta, J. C., D. P. Via, C. E. Butterfield, and B. R. Zetter. 1984. Identification and isolation of endothelial cells based on their increased uptake of acetylated-low density lipoprotein. J. Cell Biol. 99:2034.
38. Lampson, L. A., and R. Levy. 1980. Two populations of Ia-like molecules on a human B cell line. J. Immunol. 125:293.
39. Shackelford, D. A., L. A. Lampson, and J. L. Strominger. 1981. Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates. J. Immunol. 127:1403.
40. Hunt, L. A., D. W. Brown, H. L. Robinson, C. W. Naeve, and R. G. Webster. 1988. Retrovirus-expressed hemagglutinin protects against lethal influenza virus infections. J. Virol. 62:3014.
41. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680.
42. Studier, F. W. 1973. Analysis of bacteriophage T7 early RNAs and proteins on slab gels. J. Mol. Biol. 79:237.
43. Bonner, W. M., and R. A. Laskey. 1974. A film detection method for tritium-labelled proteins and nucleic acids in polyacrylamide gels. Euro. J. Biochem. 46:83.
44. Aviv, H., and P. Leder. 1972. Purification of biologically active globin messenger RNA by chromatography on oligothymidylic acid-cellulose. Proc. Natl. Acad. Sci. USA 69:1408.
45. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: A laboratory manual. 2nd Ed. N. Ford, C. Nolan, and M. Ferguson, eds. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, p. 9.31.
46. Richardson, C. C. 1971. Polynucleotide kinase from Escherichia coli infected with bacteriophage T4. Proc. Nucl. Acids Res. 2:815.
47. Maxam, A., and W. Gilbert. 1977. A new method for sequencing DNA. Proc. Natl. Acad. Sci. USA 74:560.
48. Justus, D. E., and R. D. Higginbotham. 1971. Interaction of mast cells and macrophages in vitro. J. Reticuloendothel. Soc. 10:340.
49. Kielian, M. C., R. M. Steinman, and Z. A. Cohn. 1982. Intra-lysosomal accumulation of polyanions. I. Fusion of pinocytic and phagocytic vacuoles with secondary lysosomes. J. Cell Biol. 93:866.
50. Leyva-Cobian, F., and E. R. Unanue. 1988. Intracellular interference with antigen presentation. J. Immunol. 141:1445.
51. Higginbotham, R. D., and T. F. Dougherty. 1957. Potentiation of polymyxin B toxicity by ACTH. Proc. Soc. Exp. Biol. Med. 96:466.
52. Rubin, B. Y., and S. L. Gupta. 1980. Differential efficacies of human type I and type II interferons as antiviral and antiproliferative agents. Proc. Natl. Acad. Sci. USA 77:5928.
53. Weil, J., C. J. Epstein, and L. B. Epstein. 1983. A unique set of polypeptides is induced by γ interferon in addition to those induced in common with α and β interferon. Nature 301:437.
54. Higgins, P. J., and T. J. Smith. 1993. Pleotrophic action of interferon gamma in human orbital fibroblasts. Biochim. Biophys. Acta 1181:23.
55. Lew, D. J., T. Decker, and J. E. Darnell. 1989. Alpha interferon and gamma interferon stimulate transcription of a single gene through different signal tranduction pathways. Mol. Cell. Biol. 9:5404.
56. Rubin, B. Y., S. L. Anderson, L. Xing, R. J. Powell, and W. P. Tate. 1991. Interferon induces tryptophanyl-tRNA synthetase expression in human fibroblasts. J. Biol. Chem. 266:24245.
57. Kappes, D., and J. L. Strominger. 1988. Human class II major histocompatibility complex genes and proteins. Annu. Rev. Biochem. 57:991.
58. Machamer, C. E., and P. Cresswell. 1982. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.. J. Immunol. 129:2564.
59. Blum, J. S., and P. Cresswell. 1988. Role for intracellular proteases in the processing and transport of class II HLA antigens. Proc. Natl. Acad. Sci. USA 85: 3975.
60. Hirschberg, H., L. R. Braathen, and E. Thorsby. 1982. Antigen presentation by vascular endothelial cells and epidermal Langerhans cells: the role of HLA-DR. Immunol. Rev. 66:57.
61. Nunez, G., E. J. Ball, and P. Stastny. 1983. Accessory cell function of human endothelial cells. 1. A subpopulation of Ia positive cells is required for antigen presentation. J. Immunol. 131:666.
62. Geppert, T. D., and P. E. Lipsky. 1985. Antigen presentation by interferon-γ-treated endothelial cells and fibroblasts: differential ability to function as antigen presenting cells despite comparable Ia expression. J. Immunol. 135:3750.
63. Hutchinson, I. V. 1991. Cellular mechanisms of allograft rejection. Curr. Opin. Immunol. 3:722.
64. Jackson, R. L., S. J. Busch, and A. D. Cardin. 1991. Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71:481.
65. Sakai, A., T. Ebina, and N. Ishida. 1986. Inhibition of murine L cell interferon action by heparin. Arch. Virol. 90:73.
66. Korlipara, L. V. P., H. C. C. Pleass, R. M. R. Taylor, G. Proud, J. L. R. Forsythe, and J. A. Kirby. 1994. Heparin antagonizes the induction of class II MHC molecules by interferon-γ. Transplantation 58:1426.
67. Däubener, W., S. Nockemann, M. Gutsche, and U. Hadding. 1995. Heparin inhibits the antiparasitic and immune modulatory effects of human recombinant interferon-γ. Eur. J. Immunol. 25:688.
68. Ihle, J. N., and I. M. Kerr. 1995. Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet. 11:69.
69. Pellegrini, S., and C. Schindler. 1993. Early events in signalling by interferons. Trends Biochem. Sci. 18:338.
70. Müller, M., J. Briscoe, C. Laxton, D. Guschin, A. Ziemiecki, O. Silvennoinen, A. G. Harpur, G. Barbieri, B. A. Witthuhn, C. Schindler, S. Pellegrini, A. F. Wilks, J. N. Ihle, G. R. Stark, and I. M. Kerr. 1993. The protein tyrosine kinase JAK1 complements defects in interferon-α/β and -γ signal transduction. Nature 366:129.
71. Darnell, Jr., J. E., I. M. Kerr, and G. R. Stark. 1994. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science. 264:1415.
72. Shuai, K., C. Schindler, V. R. Presiozo, and J. E. Darnell, Jr. 1992. Activation of transcription by IFN-γ: tyrosine phosphorylation of a 91-kDa DNA binding protein. Science 258:1808.
73. Shuai, K., G. R. Stark, I. M. Kerr, and J. E. Darnell. 1993. A single phosphotyrosine residue of Stat91 required for gene activation by interferon-γ. Science 261:1744.
74. Fu, X. -Y. 1995. A direct signalling pathway through tyrosine kinase activation of SH2 domain-containing transcription factors. J. Leukocyte Biol. 57:529.
75. Decker, T., D. J. Lew, J. Mirkovitch, and J. E. Darnell, Jr. 1991. Cytoplasmic activation of GAP, an IFN-α-regulated DNA-binding factor. EMBO J. 10:927.
76. Müller, M., C. Laxton, J. Briscoe, C. Schindler, T. Improta, J. E. Darnell, Jr., G. R. Stark, and I. M. Kerr. 1993. Complementation of a mutant cell line: central role of the 91-kDa polypeptide of ISGF3 in the interferon-α and -γ signal transduction pathways. EMBO J. 12:4221. st